Biden administration appeals jury finding in battle over patents for HIV prevention pills

Taking stock of the drug industry, from the lab to the medicine chest

July 8, 2024 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Rich Pedroncell/AP STAT+ | Biden administration appeals jury finding in battle over patents for HIV prevention pills At issue are patents for the lucrative HIV prevention drugs Truvada and Descovy, along with the federal government's role in their creation. By Ed Silverman STAT+ | Eli Lilly to acquire Morphic for $3.2 billion Lilly, flush with cash from sales of its blockbuster GLP-1-based treatments, has struck a number of deals and partnerships last year and this year. By Elaine Chen STAT+ | Judge rules against Boehringer Ingelheim in pharma's latest legal loss on Medicare negotiation Boehringer Ingelheim, which makes Jardiance, lost a court case challenging the constitutionality of Medicare's drug price negotiation program. By Rachel Cohrs Zhang

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser